Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Knight Therapeutics
(OP:
KHTRF
)
4.689
+0.324 (+7.41%)
Streaming Delayed Price
Updated: 3:51 PM EDT, Aug 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,700
Open
4.500
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
4.365
Today's Range
4.500 - 4.689
52wk Range
3.660 - 4.530
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
May 24, 2022
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)
Via
Benzinga
Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer
July 06, 2021
Health Canada has approved Puma Biotechnology Inc's (NASDAQ: PBYI) Nerlynx (neratinib) in combination with capecitabine for metastatic HER2-overexpressed/amplified...
Via
Benzinga
Performance
YTD
+12.57%
+12.57%
1 Month
+9.80%
+9.80%
3 Month
+15.77%
+15.77%
6 Month
+7.29%
+7.29%
1 Year
+12.22%
+12.22%
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.